Literature DB >> 18801529

Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.

Lakshmi P Kunju1, Li You, Yingxi Zhang, Stephanie Daignault, James E Montie, Cheryl T Lee.   

Abstract

PURPOSE: Lymphovascular invasion is an independent predictor of nodal invasion and survival in patients undergoing radical cystectomy. When assessed in transurethral bladder tumor resection specimens, lymphovascular invasion could predict tumor behavior and guide treatment decisions. However, the reliability of assessing lymphovascular invasion in such specimens has not been systematically evaluated. We examined the agreement of lymphovascular invasion status in matched transurethral bladder tumor resection and cystectomy specimens.
MATERIALS AND METHODS: A retrospective analysis was performed of patients undergoing transurethral bladder tumor resection within 6 weeks of cystectomy. Tumor stage and lymphovascular invasion status were assessed in transurethral bladder tumor resection specimens and compared to those in corresponding cystectomy specimens. Agreement of lymphovascular invasion status was determined using McNemar's test.
RESULTS: A total of 75 patients were eligible for study. In transurethral bladder tumor resection specimens lymphovascular invasion was identified in 17 patients (23%), including 2 (8%) in the T1 and 15 (30%) in the T2 or greater groups. In matched cystectomy specimens lymphovascular invasion was identified in 30 patients (40%), including 9 (36%) in the T1 and 21 (42%) in the T2 or greater populations. A lack of lymphovascular invasion agreement was observed between transurethral bladder tumor resection and cystectomy specimens in the entire population and in patients with cT1 tumors (p = 0.009 and 0.02, respectively). However, good concordance was seen in patients with muscle invasive disease (p = 0.13). Nodal metastasis was observed in 7 of 17 patients (41%) with detectable lymphovascular invasion in the transurethral bladder tumor resection specimen.
CONCLUSIONS: When lymphovascular invasion is identified in a transurethral bladder tumor resection sample, it will be present in the cystectomy sample in 65% of cases and associated with nodal metastasis in 41%. Lymphovascular invasion is a valuable histological tool in the evaluation of transurethral bladder tumor resection samples, particularly cT2 tumors, because there is significant agreement of lymphovascular invasion status at transurethral bladder tumor resection and at subsequent cystectomy.

Entities:  

Mesh:

Year:  2008        PMID: 18801529     DOI: 10.1016/j.juro.2008.07.056

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  17 in total

1.  Lymphovascular invasion as a predictive factor for muscle-invasive bladder cancer and its importance in a bladder-conservation treatment group.

Authors:  Hüsnü Tokgöz; Bulent Erol
Journal:  Curr Oncol       Date:  2010-04       Impact factor: 3.677

Review 2.  The prognostic role of lymphovascular invasion in urothelial carcinoma of the bladder.

Authors:  Romain Mathieu; Ilaria Lucca; Morgan Rouprêt; Alberto Briganti; Shahrokh F Shariat
Journal:  Nat Rev Urol       Date:  2016-07-19       Impact factor: 14.432

3.  Radical cystectomy for the treatment of T1 bladder cancer: the Canadian Bladder Cancer Network experience.

Authors:  Venu Chalasani; Wassim Kassouf; Joseph L Chin; Yves Fradet; Armen G Aprikian; Adrian S Fairey; Eric Estey; Louis Lacombe; Ricardo Rendon; David Bell; Ilias Cagiannos; Darrell Drachenberg; Jean-Baptiste Lattouf; Jonathan I Izawa
Journal:  Can Urol Assoc J       Date:  2011-04       Impact factor: 1.862

4.  Downstaging to non-invasive urothelial carcinoma is associated with improved outcome following radical cystectomy for patients with cT2 disease.

Authors:  Matthew K Tollefson; Stephen A Boorjian; Sara A Farmer; Igor Frank
Journal:  World J Urol       Date:  2012-03-25       Impact factor: 4.226

5.  [Validation of pre-cystectomy nomograms for the prediction of locally advanced urothelial bladder cancer in a multicentre study: are we able to adequately predict locally advanced tumour stages before surgery?].

Authors:  M May; M Burger; S Brookman-May; W Otto; J Peter; O Rud; H-M Fritsche; C Bolenz; L Trojan; E Herrmann; M S Michel; C Wülfing; R Moritz; A Tiemann; S C Müller; J Ellinger; A Buchner; C G Stief; D Tilki; W F Wieland; C Gilfrich; T Höfner; M Hohenfellner; A Haferkamp; J Roigas; P Bretschneider-Ehrenberg; O Müller; M Zacharias; S Gunia; P J Bastian
Journal:  Urologe A       Date:  2011-06       Impact factor: 0.639

6.  Accuracy and prognostic value of variant histology and lymphovascular invasion at transurethral resection of bladder.

Authors:  Mohammad Abufaraj; Shahrokh F Shariat; Beat Foerster; Carmen Pozo; Marco Moschini; David D'Andrea; Romain Mathieu; Martin Susani; Anna K Czech; Pierre I Karakiewicz; Veronika Seebacher
Journal:  World J Urol       Date:  2017-11-11       Impact factor: 4.226

7.  A 20-gene model for molecular nodal staging of bladder cancer: development and prospective assessment.

Authors:  Steven Christopher Smith; Alexander Spyridon Baras; Garrett Dancik; Yuanbin Ru; Kuan-Fu Ding; Christopher A Moskaluk; Yves Fradet; Jan Lehmann; Michael Stöckle; Arndt Hartmann; Jae K Lee; Dan Theodorescu
Journal:  Lancet Oncol       Date:  2011-01-20       Impact factor: 41.316

8.  Significance of lymphovascular invasion in organ-confined, node-negative urothelial cancer of the bladder: data from the prospective p53-MVAC trial.

Authors:  Friedrich-Carl von Rundstedt; Douglas A Mata; Susan Groshen; John P Stein; Donald G Skinner; Walter M Stadler; Richard J Cote; Oleksandr N Kryvenko; Guilherme Godoy; Seth P Lerner
Journal:  BJU Int       Date:  2015-03-25       Impact factor: 5.588

9.  Clinical and therapeutic factors associated with adverse pathological outcomes in clinically node-negative patients treated with neoadjuvant cisplatin-based chemotherapy and radical cystectomy.

Authors:  Kamran Zargar-Shoshtari; Homayoun Zargar; Colin P Dinney; Cesar E Ercole; Pranav Sharma; Evan Kovac; Petros D Grivas; Andrew J Stephenson; Jay B Shah; Peter C Black; Philippe E Spiess
Journal:  World J Urol       Date:  2015-08-19       Impact factor: 4.226

10.  Multivariate analysis of the prognostic significance of resection weight after transurethral resection of bladder tumor for non-muscle-invasive bladder cancer.

Authors:  Dae Hyeon Kwon; Phil Hyun Song; Hyun Tae Kim
Journal:  Korean J Urol       Date:  2012-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.